Multifunctional nanocomposites utilizing ruthenium (II) complex/manganese (IV) dioxide nanoparticle for synergistic reinforcing radioimmunotherapy
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Radiotherapy (RT) stands as a frontline treatment modality in clinical breast oncology, yet challenges like ROS reduction, high toxicity, non-selectivity, and hypoxia hinder efficacy. Additionally, RT administered at different doses can induce varying degrees of radioimmunotherapy. High doses of radiation (>10 Gy) may result in immune suppression, while moderate doses (4–10 Gy), although capable of mitigating the immune suppression caused by high-dose radiation, are often insufficient in effectively killing tumor cells. Therefore, enhancing the generation of ROS and ameliorating the tumor hypoxic immune-suppressive microenvironment at moderate radiation doses could potentially drive radiation-induced immune responses, offering a fundamental solution to the limitations of RT. In this study, a novel multifunctional nanoplatform, RMLF, integrating a Ru (II) complex into folate-functionalized liposomes with BSA-MnO 2 nanoparticles was proposed. Orthogonal experimental optimization enhances radiosensitization via increasing accumulation in cancer cells, elevating ROS, and contributing to a dual enhancement of the cGAS-STING-dependent type I IFN signaling pathway, aimed to overcome the insufficient DAMPs typically seen in the conventional RT at 4 Gy. Such a strategy effectively activated cytotoxic T lymphocytes for infiltration into tumor tissues and promoted the polarization of tumor-associated macrophages from the M2 to M1 phenotype, substantially bolstering immune memory responses. This pioneering approach represents the first use of a ruthenium complex in radioimmunotherapy, activating the cGAS-STING pathway to amplify immune responses, overcome RT resistance, and extend immunotherapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. 2 RMLF relieves hypoxic TME and actively targets 4T1 cells. (a)Typical oxygen generation kinetics curves of RL, RML, RMLF and MnB in the presence of H2O2 ([Mn] = 10 µg/mL, [H2O2] = 1 mM) (b, d) Quantitative analysis of the fluorescence intensity of MnB and MnB with 100 µM H2O2 by Image J (n = 3). IFM images of 4T1 cells treated with MnB ([Mn] = 10 µg/mL) for 24 h with or without H2O2 (100 µM) and stained with RDPP as an O2 probe, respectively. The scale bar represents 200 μm. (c, e) Quantitative analysis of the HIF-1α fluorescence intensity of more than 100 cells in each group by Image J (n = 3). Hypoxia-relieving efficacy of RMLF (2 µM RudZ, [Mn] = 10 µg/mL) assessed by HIF-1α immunofluorescence. The scale bar represents 50 μm. (f, g) In vitro uptake of RudZ and different liposome-based samples (2 µM RudZ) on 4T1 cells analyzed by IFM. The scale bar represents 200 μm. Quantitative analysis of the fluorescence intensity of RudZ and different liposome samples by Image J (n = 3). *** indicates p < 0.001; **** indicates p < 0.0001](https://figures.cochat.ai/paper-figures/3d762c3018514e5cad87765666170c21/multifunctional-nanocomposites-utilizing-ruthenium-ii-complex-manganese-iv-figure-2.jpg)
![Fig. 3 Evaluation of radiotherapy sensitizing activity of RMLF in vitro. (a) Cell viability of 4T1 cells treated with the RudZ (2 µM), CDDP (2 µM), MnB ([Mn] = 10 µg/mL), RML (2 µM RudZ, [Mn] = 10 µg/mL) and RMLF (2 µM RudZ, [Mn] = 10 µg/mL) (n = 3). The dose of X-ray is 4 Gy. (b, e) The quantitative analysis of survival fraction (SF) from clone formation under different treatments (n = 3). And optical photographs of clonogenic survival assay under different treatments. (c, f) Quantitative analysis of the γ-H2AX fluorescence intensity of more than 100 cells in each group by Image J (n = 3). The DNA damage effect of RMLF (2 µM RudZ, [Mn] = 10 µg/mL) was assessed by γ-H2AX immunofluorescence. The scale bars represent 200 μm. (d) Flow cytometry was employed to perform cell cycle analysis of 4T1 cells subjected to different treatments. *** indicates p < 0.001; **** indicates p < 0.0001](https://figures.cochat.ai/paper-figures/5dac25aba0664c83b89e0a8d33a1f805/multifunctional-nanocomposites-utilizing-ruthenium-ii-complex-manganese-iv-figure-3.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Immune-related effects, including immunogenic cell death, dendritic cell activation, macrophage polarization, and cGAS–STING signaling, were also described in selected studies [23,26,91].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [91]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Immune-related effects, including cGAS–STING activation and increased immune cell infiltration, have also been described following nanoparticle-assisted irradiation [18,23,26,91].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792 · cited 1×
“As cells expressing CD86 and CD80 are markers of DCs maturation [57], we used flow cytometry to analyze the effect of RMLF + X-ray treatment of 4T1 cells to induce DCs maturation.”
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Vanpouille-Box, C., Alard, A., Aryankalayil, M. J., Sarfraz, Y., Diamond, J. M., Schneider, R. J., Inghirami, G., Coleman, C. N., Formenti, S. C., & Demaria, S. (2017) · Nature Communications · doi:10.1038/ncomms15618 · Cited by 1,834
DNA sensing by the cGAS–STING pathway in health and disease
Motwani, M., Pesiridis, S., & Fitzgerald, K. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0151-1 · Cited by 1,467 · cited 1×
“Upon activation of the cGAS-STING intrinsic immune signaling pathway, NF-κB expression induces the expression of IFNs and other immune-related cytokines, thereby inducing the maturation of DCs and increasing the proportion of CD8 + T cells [56].”
Lin, L., Song, J., Song, L., Ke, K., Liu, Y., Zhou, Z., Shen, Z., Li, J., Yang, Z., Tang, W., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712027 · Cited by 1,466
A molecular light switch for DNA: Ru(bpy)2(dppz)2+
Friedman, A. E., Chambron, J. C., Sauvage, J. P., Turro, N. J., & Barton, J. K. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00168a052 · Cited by 1,412 · cited 1×
“It is well known that dppz-derived ruthenium complexes can act as molecular light switches [30], therefore, we examined the properties of RudZ using Lipo as the assembly medium.”
BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis
McArthur, K., Whitehead, L. W., Heddleston, J. M., Li, L., Padman, B. S., Oorschot, V., Geoghegan, N. D., Chappaz, S., Davidson, S., San Chin, H., et al. (2018) · Science · doi:10.1126/science.aao6047 · Cited by 1,072 · cited 1×
“The mechanism of mitochondrial release of mtDNA may be closely related to the BAX/BAK protein pathway [55].”
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017 · cited 1×
“Besides platinum-containing complexes, ruthenium polypyridyl complexes (RPCs) have been heavily studied for their dsDNA-binding, potential anticancer activity, and adjustable spectroscope and photophysical properties [7–10].”
Sun, X., Zhang, Y., Li, J., Park, K. S., Han, K., Zhou, X., Xu, Y., Nam, J., Xu, J., Shi, X., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00962-9 · Cited by 788 · cited 1×
“Recently, Mn 2+ is being exploited to activate the cGAS-STING mediated IFNs [54].”
Self-citationMitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress
Lee, H.-C., & Wei, Y.-H. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.09.010 · Cited by 666 · cited 1×
“In such instances, the copy number in the D-loop region may also correspondingly decrease [51–53].”
CD8+ T cell metabolism in infection and cancer
Reina-Campos, M., Scharping, N. E., & Goldrath, A. W. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00537-8 · Cited by 612
Exploiting the folate receptor α in oncology
Scaranti, M., Cojocaru, E., Banerjee, S., & Banerji, U. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0339-5 · Cited by 593
Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation
Zhu, P., Chen, Y., & Shi, J. (2018) · ACS Nano · doi:10.1021/acsnano.8b00999 · Cited by 572 · cited 1×
“MnB could degrade into water-soluble Mn 2+ under acidic conditions and is excreted through the renal site, which greatly improves the biosafety of RMLF and avoids the toxic effects of metal particle accumulation on normal tissues [35].”
Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
Jarosz-Biej, M., Smolarczyk, R., Cichoń, T., & Kułach, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133212 · Cited by 546 · cited 1×
“Clinical findings have indicated that intermediate-dose radiation (4–10 Gy) effectively triggers tumor cell apoptosis, without exacerbating hypoxic conditions or promoting immunosuppression, hence, we have selected 4 Gy as the radiation dosage for all subsequent experiments [46].”
Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses
Collins, L. V., Hajizadeh, S., Holme, E., Jonsson, I.-M., & Tarkowski, A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703328 · Cited by 508 · cited 1×
“And yet, the oxidized mtDNA derived from cancer cells as DAMPs has demonstrated potent immunostimulatory properties [60].”
Ju, E., Dong, K., Chen, Z., Liu, Z., Liu, C., Huang, Y., Wang, Z., Pu, F., Ren, J., & Qu, X. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201605509 · Cited by 506 · cited 1×
“The intracellular overexpressed glutathione (GSH) can reduce the RT efficiency to some extent via scavenging the ROS [40], the redox reaction between MnO 2 and GSH can be applied in the GSH depletion strategy, with the Mn 2+ product possessing catalytic properties that alleviate ROS clearance by…”
Abscopal effects of radiation therapy: A clinical review for the radiobiologist
Siva, S., MacManus, M. P., Martin, R. F., & Martin, O. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2013.09.018 · Cited by 441
Song, G., Chen, Y., Liang, C., Yi, X., Liu, J., Sun, X., Shen, S., Yang, K., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201602111 · Cited by 394 · cited 1×
“Moreover, a hypoxia inducible factor-1α (HIF-1α) immunofluorescence labeling assay was performed, HIF-1α has traditionally been thought to be a vital marker of tumor hypoxia [39].”
Minimizing the damage: repair pathways keep mitochondrial DNA intact
Kazak, L., Reyes, A., & Holt, I. J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3439 · Cited by 388 · cited 2×
“Mitochondrial matrix containing mitochondrial DNA (mtDNA), unlike nuclear dsDNA, mtDNA is characterized by a circular loop and located outside of the nucleus without histone protection and lack of nucleotide excision repair, which make it more susceptible to radiation-induced DNA damage [20].”
The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases
Nakahira, K., Hisata, S., & Choi, A. M. K. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6407 · Cited by 360 · cited 1×
“Once the mitochondrial integrity was compromised, cytoplasmic oxidized mtDNA leakage as damage-associated molecular patterns (DAMPs) to constantly stimulate the cGAS-STING pathway to media innate immunity with IFNs secretion [21, 22].”
Mayer, L. D., Tai, L. C. L., Ko, D. S. C., Masin, D., Ginsberg, R. S., Cullis, P. R., & Bally, M. B. (1989) · PubMed · Cited by 353
In D-loop: 40years of mitochondrial 7S DNA
Nicholls, T. J., & Minczuk, M. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.03.027 · Cited by 285
Meng, L., Cheng, Y., Tong, X., Gan, S., Ding, Y., Zhang, Y., Wang, C., Xu, L., Zhu, Y., Wu, J., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b03590 · Cited by 268
Liu, Z., Xu, K., Sun, H., & Yin, S. (2015) · Small · doi:10.1002/smll.201402222 · Cited by 264
Huang, C., Lin, B., Chen, C., Wang, H., Lin, X., Liu, J., Ren, Q., Tao, J., Zhao, P., & Xu, Y. (2022) · Advanced Materials · doi:10.1002/adma.202207593 · Cited by 224
Ma, Z., Jia, X., Bai, J., Ruan, Y., Wang, C., Li, J., Zhang, M., & Jiang, X. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604258 · Cited by 218
Zhang, D.-Y., Zheng, Y., Tan, C.-P., Sun, J.-H., Zhang, W., Ji, L.-N., & Mao, Z.-W. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b13808 · Cited by 192
He, L., Huang, Y., Zhu, H., Pang, G., Zheng, W., Wong, Y., & Chen, T. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201303533 · Cited by 185 · cited 1×
“Besides platinum-containing complexes, ruthenium polypyridyl complexes (RPCs) have been heavily studied for their dsDNA-binding, potential anticancer activity, and adjustable spectroscope and photophysical properties [7–10].”
Lu, Z., Gao, J., Fang, C., Zhou, Y., Li, X., & Han, G. (2020) · Advanced Science · doi:10.1002/advs.202001223 · Cited by 161 · cited 1×
“Considering the overexpressed endogenic H 2 O 2 in TME, designing and synthesizing catalase-like inorganic nanomaterials such as platinum nanoparticles (Pt NPs), manganese dioxide (MnO 2 ) and cerium oxide (CeO 2 ) to elevate the O 2 level in situ is one approach to combat hypoxia [4–6].”
Ruthenium( ii ) complexes with dppz: from molecular photoswitch to biological applications
Li, G., Sun, L., Ji, L., & Chao, H. (2016) · Dalton Transactions · doi:10.1039/c6dt01624c · Cited by 157
Wang, C., Sun, Z., Zhao, C., Zhang, Z., Wang, H., Liu, Y., Guo, Y., Zhang, B., Gu, L., Yu, Y., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.036 · Cited by 146
Jiang, H., Guo, Y., Wei, C., Hu, P., & Shi, J. (2021) · Advanced Materials · doi:10.1002/adma.202008065 · Cited by 144 · cited 1×
“…another major cause of low immune responsiveness is the suppression of immune cells in the tumor, such as tumor-associated macrophages (TAMs), regulatory T cells (Tregs), etc., which always lead to immunotherapy failure by limiting T cell infiltration and depleting cytotoxic T lymphocytes [58, 59].”
Ling, Y., Xia, X., Liang, H., Wang, W., Zhang, H., Liu, L., Liu, W., Li, Z., Tan, C., & Mao, Z. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202210988 · Cited by 134 · cited 1×
“Once the mitochondrial integrity was compromised, cytoplasmic oxidized mtDNA leakage as damage-associated molecular patterns (DAMPs) to constantly stimulate the cGAS-STING pathway to media innate immunity with IFNs secretion [21, 22].”
Mitochondria as a target in cancer treatment
Liu, Y., & Shi, Y. (2020) · MedComm · doi:10.1002/mco2.16 · Cited by 130
Sun, Q., Bi, H., Wang, Z., Li, C., Wang, C., Xu, J., Yang, D., He, F., Gai, S., & Yang, P. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b11607 · Cited by 117
Zheng, S.-J., Yang, M., Luo, J., Liu, R., Song, J., Chen, Y., & Du, J. (2023) · ACS Nano · doi:10.1021/acsnano.3c03962 · Cited by 115 · cited 1×
“Emerging researches demonstrated that manganese ions (Mn 2+ ) as a catalytic cofactor binding to cGAS, also participate in activating innate immunity via the imperative activation of the cGAS-STING signaling pathway in a dsDNA-independent mode [23– 25].”
Zhang, H., Yan, Q., Wang, X., Chen, X., Chen, Y., Du, J., & Chen, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6670579 · Cited by 114 · cited 1×
“Mitochondrial damage typically coincides with alterations in mitochondrial membrane permeability (MMP) [48], with MMP changes being the most common manifestation of mitochondrial dysfunction, frequently detected through the JC-1 assay.”
Chen, J., Chen, Q., Liang, C., Yang, Z., Zhang, L., Yi, X., Dong, Z., Chao, Y., Chen, Y., & Liu, Z. (2017) · Nanoscale · doi:10.1039/c7nr05316a · Cited by 95 · cited 1×
“Mean-while, even high concentrations of MnB ([Mn] = 20 µg/ mL) did not cause significant effects on 4T1 cells and had good biocompatibility, in according with similar research [45].”
Self-citationPan, J., Wang, Y., Pan, H., Zhang, C., Zhang, X., Fu, Y.-Y., Zhang, X., Yu, C., Sun, S.-K., & Yan, X.-P. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201603440 · Cited by 80 · cited 1×
“1d), the experimental XRD profile of the MnB and RMLF share similar distinct peaks, which were in good match with the characteristic peak of simulated MnO 2 [31],implying the presence of MnO 2 in MnB and RMLF.”
Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy
Song, W. L., Song, S., Kuang, J., Yang, H., Yu, T., Yang, F., Wan, T. Y., Xu, Y., Wei, S., Li, M.-X., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c03509 · Cited by 79 · cited 1×
“However, with histones protection and host DNase digestion, nuclear dsDNA seems to be a weak activator of cGAS, thereby hindering antitumor immunity [15, 16].”
Silva, V. R., Corrêa, R. S., Santos, L. D. S., Soares, M. B. P., Batista, A. A., & Bezerra, D. P. (2018) · Scientific Reports · doi:10.1038/s41598-017-18639-6 · Cited by 78 · cited 1×
“…typically exhibit a higher mitochondrial membrane potential (-180 mV), allowing positively charged metal complexes to target mitochondria by modulating the lipid solubility of organic ligands or introducing mitochondria-targeted classical functional groups, such as triphenylphosphine [18, 19].”
Lei, H., Li, Q., Li, G., Wang, T., Lv, X., Pei, Z., Gao, X., Yang, N., Gong, F., Yang, Y., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.07.026 · Cited by 77 · cited 1×
“Emerging researches demonstrated that manganese ions (Mn 2+ ) as a catalytic cofactor binding to cGAS, also participate in activating innate immunity via the imperative activation of the cGAS-STING signaling pathway in a dsDNA-independent mode [23– 25].”
An, J., Liu, M., Zhao, L., Lu, W., Wu, S., Zhang, K., Liu, J., Zhang, Z., & Shi, J. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202201275 · Cited by 69
Zhang, D., Zheng, Y., Zhang, H., He, L., Tan, C., Sun, J., Zhang, W., Peng, X., Zhan, Q., Ji, L., et al. (2017) · Nanoscale · doi:10.1039/c7nr05349e · Cited by 67 · cited 1×
“However, lower temperature, energy metabolism inhibitor as well as endocytosis inhibitor all substantially diminished the uptake efficiency of RMLF by 4T1 cells, indicating that RMLF entered the cells through endocytosis [42].”
Heat-activated drug delivery increases tumor accumulation of synergistic chemotherapies
Dunne, M., Epp-Ducharme, B., Sofias, A. M., Regenold, M., Dubins, D. N., & Allen, C. J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.012 · Cited by 63 · cited 1×
“We optimized the preparation conditions of RMLF by consulting the literature and orthogonal experimental design (Table S1, S2) [28].”
Characterization of CC‐chemokine receptor 7 expression on murine T cells in lymphoid tissues
Björkdahl, O., Barber, K. A., Brett, S. J., Daly, M. G., Plumpton, C., Elshourbagy, N. A., Tite, J. P., & Thomsen, L. L. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01727.x · Cited by 62 · cited 1×
“Then, the content of effector memory T cells (T em ) and central memory T cells (T cm ) is a key indicator to evaluate the long-term immune memory effect, and their cell phenotypes may be defined as CD44 hi CD62L lo and CD44 hi CD62L hi [61, 63].”
Pan, S., Huang, G., Sun, Z., Chen, X., Xiang, X., Jiang, W., Xu, Y., Chen, T., & Zhu, X. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202213364 · Cited by 55
Formation of Sequence‐Independent Z‐DNA Induced by a Ruthenium Complex at Low Salt Concentrations
Wu, Z., Tian, T., Yu, J., Weng, X., Liu, Y., & Zhou, X. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201104422 · Cited by 53 · cited 1×
“The 1 H-NMR of RudZ confirmed the presence of the dppz and ancillary ligands DIP, as reported by others (Figure S1) [29].”
Prachařová, J., Novohradský, V., Kostrhunová, H., Štarha, P., Trávníček, Z., Kašpárková, J., & Brabec, V. (2018) · Dalton Transactions · doi:10.1039/c8dt02236d · Cited by 49 · cited 1×
“…strategies as follows: (1) [Ru (DIP) 2 dppz] 2+ (RudZ) with more hydrophobic ancillary ligands DIP and classical DNA binding group dppz, which make it more easily to be entrapped in the lipid bilayer of liposome (Lipo), so as to significantly improve the solubility and bioavailability of RudZ [26].”
Sahu, G., Patra, S. A., Lima, S., Das, S., Görls, H., Plass, W., & Dinda, R. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202202694 · Cited by 48 · cited 1×
“…typically exhibit a higher mitochondrial membrane potential (-180 mV), allowing positively charged metal complexes to target mitochondria by modulating the lipid solubility of organic ligands or introducing mitochondria-targeted classical functional groups, such as triphenylphosphine [18, 19].”
Precise Engineering of a Se/Te Nanochaperone for Reinvigorating Cancer Radio‐Immunotherapy
Chang, Y., Huang, J., Shi, S., Xu, L., Lin, H., & Chen, T. (2023) · Advanced Materials · doi:10.1002/adma.202212178 · Cited by 47 · cited 1×
“…recently, a study proposed a structurally controlled nanoheterojunction for direct destruction of tumor cells and shaping the tumor immune microenvironment to effectively promote RT, producing a dramatic “abscopal effect” in combination therapy mode to prevent tumor recurrence and metastasis [14].”
Octopod PtCu Nanoframe for Dual-Modal Imaging-Guided Synergistic Photothermal Radiotherapy
Li, J., Zu, X., Liang, G., Zhang, K., Liu, Y., Li, K., Luo, Z. Y., & Cai, K. (2018) · Theranostics · doi:10.7150/thno.22557 · Cited by 41 · cited 1×
“Furthermore, RT alone or in combination with other types of therapies such as surgery, chemotherapy, or immunotherapy are applied to an estimated 60% of all cancer patients at some point during their treatment [2, 3].”
Diagnostic and therapeutic nanoenzymes for enhanced chemotherapy and photodynamic therapy
Cong, C., He, Y., Zhao, S., Zhang, X., Li, L., Wang, D., Liu, L., & Gao, D. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02791j · Cited by 37 · cited 1×
“The UV − Vis spectrum of RMLF exhibited the characteristic absorption peaks of RudZ, MnB and FA at 279, 290, 363 and 458 nm, respectively, also confirmed above conclusion [33, 34] (Figure S5).”
Yu, Y., Liu, T., Yu, G., Wang, H., Du, Z., Chen, Y., Yang, N., Cao, K., Liu, C., Wan, Z., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05402-7 · Cited by 34 · cited 1×
“We evaluated the damage status by immunofluorescence probing with γ-H2AX expression which is correlate with the amount of unrepair dsDNA breaks [47].”
Du, B., Ding, X., Wang, H., Du, Q., Xu, T., Huang, J., Zhou, J., & Cheng, G. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00546c · Cited by 32 · cited 1×
“Next, we intended to determine whether RMLF can generate oxygen in simulated TME with 1 mM H 2 O 2 [37].”
8-oxodG accumulation within super-enhancers marks fragile CTCF-mediated chromatin loops
Scala, G., Gorini, F., Ambrosio, S., Chiariello, A. M., Nicodemi, M., Lania, L., Majello, B., & Amente, S. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac143 · Cited by 26 · cited 1×
“8-hydroxydeoxyguanosine (8-OH-dG) as a major marker of oxidative mtDNA damage, is selected to assess the potential of RMLF + X-ray group to damage the mtDNA by immunofluorescence staining and quantitative fluorescence measurements [50].”
Deng, Z., Yu, L., Cao, W., Zheng, W., & Chen, T. (2015) · ChemMedChem · doi:10.1002/cmdc.201500127 · Cited by 25 · cited 1×
“Moreover, RPCs can sensitize RT by means of activating the p53 pathway, regulating cell cycle arrest, and promoting intracellular ROS levels [11].”
He, L., Xiong, K., Wang, L., Guan, R., Chen, Y., Ji, L., & Chao, H. (2021) · Chemical Communications · doi:10.1039/d1cc02178h · Cited by 22 · cited 1×
“4b) [49].”
FitzGerald, T. J., Bishop‐Jodoin, M., Laurie, F., Lukez, A. P., O’Loughlin, L., & Sacher, A. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.08.010 · Cited by 20
Biocompatible ruthenium polypyridyl complexes as efficient radiosensitizers
Xiong, Z., Zhong, J., Zhao, Z., & Chen, T. (2019) · Dalton Transactions · doi:10.1039/c9dt00333a · Cited by 13 · cited 1×
“…a PEGylated ruthenium polypyridyl complex capable of self-assembling into nanoparticles in aqueous solution by π-π stacking interaction, hydrophobic effect, hydrogen bond and van der Waals force, which promote its accumulation in tumor sites by enhanced permeability and retention (EPR) [12].”
Li, M., Liu, J., Luo, X., Zhao, Z., Wang, S., Liu, Z., Li, T., Yang, D. K., Li, Y., Wang, P., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202418 · Cited by 8 · cited 1×
“Considering the overexpressed endogenic H 2 O 2 in TME, designing and synthesizing catalase-like inorganic nanomaterials such as platinum nanoparticles (Pt NPs), manganese dioxide (MnO 2 ) and cerium oxide (CeO 2 ) to elevate the O 2 level in situ is one approach to combat hypoxia [4–6].”
Huang, L.-L., Xu, J., Jin, Y., Zhao, D., & Xie, H. (2016) · The Analyst · doi:10.1039/c5an02650d · Cited by 8 · cited 1×
“The UV − Vis spectrum of RMLF exhibited the characteristic absorption peaks of RudZ, MnB and FA at 279, 290, 363 and 458 nm, respectively, also confirmed above conclusion [33, 34] (Figure S5).”
Cited by
Chen, D., Liu, A., Wang, Z., Wang, C., Hu, J., Wang, D., & Yao, D. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.217976 · Cited by 4
Rong, J., Lv, F., Wang, R., Li, H., Zhang, Q., & Hu, X. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c00688 · Cited by 4
Progress and prospects of metal-based immunotherapy in breast cancer
Liang, J., Yang, X., & Zhang, Y. (2025) · BioMetals · doi:10.1007/s10534-025-00747-w · Cited by 3
“Additionally, a novel multifunctional nanoplatform, RMLF, combining rhodium (II) complexes with BSA-MnO ₂ nanoparticles, has been developed to enhance ROS generation and activate the cGAS-STING pathway, thereby improving immune responses during radiotherapy (Peng et al. 2024).”
Mechanisms and Applications of Manganese-Based Materials in Tumor Immunotherapy
Kong, X., Zhang, C., Hu, H., Chen, Y., Gao, W., & Chen, R. (2026) · Molecules · doi:10.3390/molecules31101704 · Cited by 3
“This effectively promotes CTL infiltration and the polarization of macrophages from M2 to M1, significantly enhancing immune memory responses and overcoming the issue of insufficient DAMP release during conventional RT (4 Gy) [110].”
Jiang, M., Chen, M., Zou, W., Xie, Y., Shi, J., Liu, J., Chen, A., & Zhao, X. R. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.11.012 · Cited by 1
Metadata
- Authors
- Peng, J., Quan, D.-L., Yang, G., Wei, L.-T., Yang, Z., Dong, Z.-Y., Zou, Y.-M., Hou, Y.-K., Chen, J.-X., Lv, L., & Sun, B.
- Affiliations
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Southern Medical University Shenzhen Hospital (CN)
- Jinan University (CN)
- Southern Medical University (CN)
- Corresponding author
- Lv, Lin
- Sun, Bin
- Venue
- Journal of Nanobiotechnology
- Published
- 2024-11-27
- Volume
- 22
- Issue
- 1
- Pages
- 735-735
- ISSN
- 1477-3155 (ISSN-L)
- PMC
- PMC11600833
- OpenAlex
- W4404731262
- Cited by
- 9
- References
- 63
- Citations by year
- 2026: 6 · 2025: 3
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Journal of Nanobiotechnology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the Characteristic Innovation Projects of Colleges and Universities in Guangdong Province (2018KTSCX028)
- the Open Funding of MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, Sun Yat-Sen University (BISC2022A03)
- the Student Innovation and Entrepreneurship Training Program Project of Southern Medical University (S202212121191)
- National Natural Science Foundation of China (82204415)
- the Guangdong Basic and Applied Basic Research Foundation (2021A1515220187)
- Guangdong Science and Technology Department of China (2023A1515012633)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- radioimmunotherapy, ruthenium(II) complexes, manganese dioxide nanoparticles, radiosensitization, reactive oxygen species, tumor hypoxia, cGAS-STING pathway, type I interferon signaling, radiation-induced immune response, tumor-associated macrophage polarization, cytotoxic T lymphocytes, breast cancer, nanocomposite drug delivery
- MeSH terms
- Multifunctional Nanoparticles, Animals, Breast Neoplasms, Female, Humans, Liposomes, Mice, Inbred BALB C, Oxides, Radiation-Sensitizing Agents, Ruthenium, Radioimmunotherapy, Reactive Oxygen Species, Manganese Compounds, Cell Line, Tumor, Mice, Nanoparticles, Nanocomposites, Coordination Complexes, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.